Literature DB >> 24550531

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.

Davide Capodanno1, Dominick J Angiolillo.   

Abstract

Entities:  

Keywords:  anticoagulants; atrial fibrillation; stents

Mesh：

Substances：

Year:  2014        PMID： 24550531     DOI： 10.1161/CIRCINTERVENTIONS.113.001150

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  17 in total

Review 1.  Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.

Authors:  Massimo Leggio; Augusto Fusco; Paolo Severi; Mario Lombardi; Elisa Caldarone; Stefania D'Emidio; Massimo Armeni; Daniela Mereu; Maria Grazia Bendini; Andrea Mazza
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

2.  A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

Authors:  Bory Kea; Tahroma Alligood; Vincent Manning; Merritt Raitt
Journal:  Curr Emerg Hosp Med Rep       Date:  2016-07-06

3.  Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.

Authors:  Matthew W Sherwood; Derek D Cyr; W Schuyler Jones; Richard C Becker; Scott D Berkowitz; Jeffrey B Washam; Günter Breithardt; Keith A A Fox; Jonathan L Halperin; Graeme J Hankey; Daniel E Singer; Jonathan P Piccini; Christopher C Nessel; Kenneth W Mahaffey; Manesh R Patel
Journal:  JACC Cardiovasc Interv       Date:  2016-08-22       Impact factor: 11.195

4.  Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.

Authors:  Brian J Potter; Giuseppe Andò; Giovanni Cimmino; Ricardo Ladeiras-Lopes; Zied Frikah; Xin Yue Chen; Vittorio Virga; Joao Goncalves-Almeida; A John Camm; Keith A A Fox
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

Review 5.  Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma.

Authors:  Jung Rae Cho; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

6.  Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.

Authors:  Donny Hanjaya-Putra; Carolyn Haller; Xiaowei Wang; Erbin Dai; Bock Lim; Liying Liu; Patrick Jaminet; Joy Yao; Amy Searle; Thomas Bonnard; Christoph E Hagemeyer; Karlheinz Peter; Elliot L Chaikof
Journal:  JCI Insight       Date:  2018-08-09

Review 7.  Novel antiplatelet agents in acute coronary syndrome.

Authors:  Francesco Franchi; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2014-10-07       Impact factor: 32.419

8.  Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Authors:  Essa Hariri; Darleen Lessard; Joel Gore; Jeffrey Rade; Robert Goldberg
Journal:  Cardiovasc Revasc Med       Date:  2019-05-02

9.  Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: A meta-analysis.

Authors:  Jing Jin; Xiaojun Zhuo; Mou Xiao; Zhiming Jiang; Linlin Chen; Yashvina Devi Shamloll
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

10.  Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis.

Authors:  Jing-Xiu Li; Yang Li; Shu-Jun Yan; Bai-He Han; Zhao-Yan Song; Wei Song; Shi-Hao Liu; Ji-Wei Guo; Shuo Yin; Ye-Ping Chen; De-Jun Xia; Xin Li; Xue-Qi Li; En-Ze Jin
Journal:  Biomed Rep       Date:  2017-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.